Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

Proteomic and Membrane Lipid Correlates of Reduced Host Defense Peptide.

Kohler C, Proctor RA, Bayer AS, Yeaman MR, Lalk M, Engelmann S, Mishra NN.

Antibiotics (Basel). 2019 Sep 28;8(4). pii: E169. doi: 10.3390/antibiotics8040169.

2.

Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients.

Mba Medie F, Sharma-Kuinkel BK, Ruffin F, Chan LC, Rossetti M, Chang YL, Park LP, Bayer AS, Filler SG, Ahn R, Reed EF, Gjertson D, Yeaman MR, Fowler VG Jr; MRSA Systems Immunobiology Group.

Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20087-20096. doi: 10.1073/pnas.1909849116. Epub 2019 Sep 16.

3.

Correction to: In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.

Abdulreda MH, Molano RD, Faleo G, Lopez-Cabezas M, Shishido A, Ulissi U, Fotino C, Hernandez LF, Tschiggfrie A, Aldrich VR, Tamayo-Garcia A, Bayer AS, Ricordi C, Caicedo A, Buchwald P, Pileggi A, Berggren PO.

Diabetologia. 2019 Aug;62(8):1517. doi: 10.1007/s00125-019-4922-1.

PMID:
31190158
4.

Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.

Pericàs JM, Nathavitharana R, Garcia-de-la-Mària C, Falces C, Ambrosioni J, Almela M, García-González J, Quintana E, Marco F, Moreno A, Bayer AS, Miró JM, Karchmer AW; Hospital Clínic Endocarditis Study Group.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00516-19. doi: 10.1128/AAC.00516-19. Print 2019 Aug.

PMID:
31182540
5.

Phenotypic and Genotypic Characteristics of Methicillin-Resistant Staphylococcus aureus (MRSA) Related to Persistent Endovascular Infection.

Li L, Yeaman MR, Bayer AS, Xiong YQ.

Antibiotics (Basel). 2019 May 29;8(2). pii: E71. doi: 10.3390/antibiotics8020071. Review.

6.

In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.

Abdulreda MH, Molano RD, Faleo G, Lopez-Cabezas M, Shishido A, Ulissi U, Fotino C, Hernandez LF, Tschiggfrie A, Aldrich VR, Tamayo-Garcia A, Bayer AS, Ricordi C, Caicedo A, Buchwald P, Pileggi A, Berggren PO.

Diabetologia. 2019 Jul;62(7):1237-1250. doi: 10.1007/s00125-019-4879-0. Epub 2019 May 14. Erratum in: Diabetologia. 2019 Jun 12;:.

PMID:
31087105
7.

Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.

Reed JM, Gardner SG, Mishra NN, Bayer AS, Somerville GA.

J Antimicrob Chemother. 2019 Aug 1;74(8):2274-2283. doi: 10.1093/jac/dkz194.

PMID:
31074482
8.

Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics.

Ersoy SC, Abdelhady W, Li L, Chambers HF, Xiong YQ, Bayer AS.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00496-19. doi: 10.1128/AAC.00496-19. Print 2019 Jul.

9.

Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.

Kebriaei R, Rice SA, Stamper KC, Seepersaud R, Garcia-de-la-Maria C, Mishra NN, Miro JM, Arias CA, Tran TT, Sullam PM, Bayer AS, Rybak MJ.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00386-19. doi: 10.1128/AAC.00386-19. Print 2019 Jun.

PMID:
30962347
10.

The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant Staphylococcus aureus Bacteriolysis.

Indiani C, Sauve K, Raz A, Abdelhady W, Xiong YQ, Cassino C, Bayer AS, Schuch R.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02291-18. doi: 10.1128/AAC.02291-18. Print 2019 Apr.

11.

Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.

Ernst CM, Slavetinsky CJ, Kuhn S, Hauser JN, Nega M, Mishra NN, Gekeler C, Bayer AS, Peschel A.

MBio. 2018 Dec 18;9(6). pii: e01659-18. doi: 10.1128/mBio.01659-18.

12.

Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.

Tran TT, Mishra NN, Seepersaud R, Diaz L, Rios R, Dinh AQ, Garcia-de-la-Maria C, Rybak MJ, Miro JM, Shelburne SA, Sullam PM, Bayer AS, Arias CA.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01531-18. doi: 10.1128/AAC.01531-18. Print 2019 Feb.

13.

Role of Purine Biosynthesis in Persistent Methicillin-Resistant Staphylococcus aureus Infection.

Li L, Abdelhady W, Donegan NP, Seidl K, Cheung A, Zhou YF, Yeaman MR, Bayer AS, Xiong YQ.

J Infect Dis. 2018 Sep 22;218(9):1367-1377. doi: 10.1093/infdis/jiy340.

14.

Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.

Zapata B, Alvarez DN, Farah S, Garcia-de-la-Maria C, Miro JM, Sakoulas G, Bayer AS, Mishra NN.

Curr Microbiol. 2018 Aug;75(8):1062-1067. doi: 10.1007/s00284-018-1491-3. Epub 2018 Apr 12.

PMID:
29651552
15.

Impact of Multiple Single-Nucleotide Polymorphisms Within mprF on Daptomycin Resistance in Staphylococcus aureus.

Yang SJ, Mishra NN, Kang KM, Lee GY, Park JH, Bayer AS.

Microb Drug Resist. 2018 Oct;24(8):1075-1081. doi: 10.1089/mdr.2017.0156. Epub 2018 Jan 30.

16.

A Case of Early Prosthetic Valve Endocarditis Caused by Staphylococcus warneri in a Patient Presenting With Congestive Heart Failure.

Kuvhenguhwa MS, Belgrave KO, Shah SU, Bayer AS, Miller LG.

Cardiol Res. 2017 Oct;8(5):236-240. doi: 10.14740/cr588w. Epub 2017 Oct 27.

17.

Dissecting Out the Direct Impacts of Large-Scale Antimicrobial Stewardship Interventions on Clinical Outcomes: Can Confounding Be Overcome?

Dilworth TJ, Rose WE, Sakoulas G, Bayer AS.

Clin Infect Dis. 2017 Nov 13;65(11):1956-1957. doi: 10.1093/cid/cix676. No abstract available.

PMID:
29020207
18.

A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.

Xiong YQ, Estellés A, Li L, Abdelhady W, Gonzales R, Bayer AS, Tenorio E, Leighton A, Ryser S, Kauvar LM.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00904-17. doi: 10.1128/AAC.00904-17. Print 2017 Oct.

19.

Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).

Yim J, Smith JR, Singh NB, Rice S, Stamper K, Garcia de la Maria C, Bayer AS, Mishra NN, Miró JM, Tran TT, Arias CA, Sullam P, Rybak MJ.

J Antimicrob Chemother. 2017 Aug 1;72(8):2290-2296. doi: 10.1093/jac/dkx130.

20.

Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

Garcia-de-la-Maria C, Xiong YQ, Pericas JM, Armero Y, Moreno A, Mishra NN, Rybak MJ, Tran TT, Arias CA, Sullam PM, Bayer AS, Miro JM.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02418-16. doi: 10.1128/AAC.02418-16. Print 2017 May.

21.

Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.

Kang KM, Mishra NN, Park KT, Lee GY, Park YH, Bayer AS, Yang SJ.

J Microbiol. 2017 Feb;55(2):153-159. doi: 10.1007/s12275-017-6509-1. Epub 2017 Jan 26.

22.

Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism.

Mishra NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, Faull K, Yoon A, Proctor R, Miro JM, Rybak MJ, Bayer AS, Arias CA, Sullam PM.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02435-16. doi: 10.1128/AAC.02435-16. Print 2017 Apr.

23.

Redeploying β-Lactams Against Staphylococcus aureus: Repurposing With a Purpose.

Bayer AS, Xiong YQ.

J Infect Dis. 2017 Jan 1;215(1):11-13. doi: 10.1093/infdis/jiw464. Epub 2016 Nov 14. No abstract available.

PMID:
28077581
24.

Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains.

Abdelhady W, Bayer AS, Gonzales R, Li L, Xiong YQ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01877-16. doi: 10.1128/AAC.01877-16. Print 2017 Feb.

25.

Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci.

Miller WR, Bayer AS, Arias CA.

Cold Spring Harb Perspect Med. 2016 Nov 1;6(11). pii: a026997. doi: 10.1101/cshperspect.a026997. Review.

26.

Infective endocarditis.

Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG Jr.

Nat Rev Dis Primers. 2016 Sep 1;2:16059. doi: 10.1038/nrdp.2016.59. Review.

27.

The Global Regulon sarA Regulates β-Lactam Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus In Vitro and in Endovascular Infections.

Li L, Cheung A, Bayer AS, Chen L, Abdelhady W, Kreiswirth BN, Yeaman MR, Xiong YQ.

J Infect Dis. 2016 Nov 1;214(9):1421-1429. Epub 2016 Aug 19.

28.

Comparative efficacy of telavancin and daptomycin in experimental endocarditis due to multi-clonotype MRSA strains.

Xiong YQ, Abdelhady W, Tang C', Bayer AS.

J Antimicrob Chemother. 2016 Oct;71(10):2890-4. doi: 10.1093/jac/dkw249. Epub 2016 Jun 26.

29.

Comparative Efficacies of Tedizolid Phosphate, Linezolid, and Vancomycin in a Murine Model of Subcutaneous Catheter-Related Biofilm Infection Due to Methicillin-Susceptible and -Resistant Staphylococcus aureus.

Bayer AS, Abdelhady W, Li L, Gonzales R, Xiong YQ.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):5092-6. doi: 10.1128/AAC.00880-16. Print 2016 Aug.

30.

Binding of Daptomycin to Anionic Lipid Vesicles Is Reduced in the Presence of Lysyl-Phosphatidylglycerol.

Khatib TO, Stevenson H, Yeaman MR, Bayer AS, Pokorny A.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):5051-3. doi: 10.1128/AAC.00744-16. Print 2016 Aug.

31.

Dysregulation of mprF and dltABCD expression among daptomycin-non-susceptible MRSA clinical isolates.

Bayer AS, Mishra NN, Cheung AL, Rubio A, Yang SJ.

J Antimicrob Chemother. 2016 Aug;71(8):2100-4. doi: 10.1093/jac/dkw142. Epub 2016 Apr 27.

32.

The GraS Sensor in Staphylococcus aureus Mediates Resistance to Host Defense Peptides Differing in Mechanisms of Action.

Chaili S, Cheung AL, Bayer AS, Xiong YQ, Waring AJ, Memmi G, Donegan N, Yang SJ, Yeaman MR.

Infect Immun. 2015 Nov 23;84(2):459-66. doi: 10.1128/IAI.01030-15. Print 2016 Feb.

33.

Endovascular infections caused by methicillin-resistant Staphylococcus aureus are linked to clonal complex-specific alterations in binding and invasion domains of fibronectin-binding protein A as well as the occurrence of fnbB.

Xiong YQ, Sharma-Kuinkel BK, Casillas-Ituarte NN, Fowler VG Jr, Rude T, DiBartola AC, Lins RD, Abdel-Hady W, Lower SK, Bayer AS.

Infect Immun. 2015 Dec;83(12):4772-80. doi: 10.1128/IAI.01074-15. Epub 2015 Sep 28.

34.

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council.

Circulation. 2015 Oct 13;132(15):1435-86. doi: 10.1161/CIR.0000000000000296. Epub 2015 Sep 15. Review. Erratum in: Circulation. 2015 Oct 27;132(17):e215. Circulation. 2016 Aug 23;134(8):e113. Circulation. 2018 Jul 31;138(5):e78-e79.

PMID:
26373316
35.

Evolving resistance among Gram-positive pathogens.

Munita JM, Bayer AS, Arias CA.

Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S48-57. doi: 10.1093/cid/civ523. Review.

36.

Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis: Analysis From the International Collaboration on Endocarditis-Prospective Echo Cohort Study.

Lauridsen TK, Park L, Tong SY, Selton-Suty C, Peterson G, Cecchi E, Afonso L, Habib G, Paré C, Tamin S, Dickerman S, Bayer AS, Johansson MC, Chu VH, Samad Z, Bruun NE, Fowler VG Jr, Crowley AL.

Circ Cardiovasc Imaging. 2015 Jul;8(7):e003397. doi: 10.1161/CIRCIMAGING.114.003397.

37.
38.

Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.

Gaupp R, Lei S, Reed JM, Peisker H, Boyle-Vavra S, Bayer AS, Bischoff M, Herrmann M, Daum RS, Powers R, Somerville GA.

Antimicrob Agents Chemother. 2015 Jul;59(7):4226-38. doi: 10.1128/AAC.00160-15. Epub 2015 May 11.

39.

Candida infective endocarditis: an observational cohort study with a focus on therapy.

Arnold CJ, Johnson M, Bayer AS, Bradley S, Giannitsioti E, Miró JM, Tornos P, Tattevin P, Strahilevitz J, Spelman D, Athan E, Nacinovich F, Fortes CQ, Lamas C, Barsic B, Fernández-Hidalgo N, Muñoz P, Chu VH.

Antimicrob Agents Chemother. 2015 Apr;59(4):2365-73. doi: 10.1128/AAC.04867-14. Epub 2015 Feb 2.

40.

Early agr activation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections.

Abdelhady W, Chen L, Bayer AS, Seidl K, Yeaman MR, Kreiswirth BN, Xiong YQ.

J Antimicrob Chemother. 2015 May;70(5):1443-52. doi: 10.1093/jac/dku547. Epub 2015 Jan 5.

41.

Editorial commentary: surgical therapy for Staphylococcus aureus prosthetic valve endocarditis: proceed with caution (Caveat Emptor).

Karchmer AW, Bayer AS.

Clin Infect Dis. 2015 Mar 1;60(5):750-2. doi: 10.1093/cid/ciu877. Epub 2014 Nov 10. No abstract available.

PMID:
25389250
42.

A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.

Reyes J, Panesso D, Tran TT, Mishra NN, Cruz MR, Munita JM, Singh KV, Yeaman MR, Murray BE, Shamoo Y, Garsin D, Bayer AS, Arias CA.

J Infect Dis. 2015 Apr 15;211(8):1317-25. doi: 10.1093/infdis/jiu602. Epub 2014 Oct 31.

43.

Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.

Bayer AS, Mishra NN, Sakoulas G, Nonejuie P, Nast CC, Pogliano J, Chen KT, Ellison SN, Yeaman MR, Yang SJ.

Antimicrob Agents Chemother. 2014 Dec;58(12):7462-7. doi: 10.1128/AAC.03422-14. Epub 2014 Oct 6.

44.

Site-specific mutation of the sensor kinase GraS in Staphylococcus aureus alters the adaptive response to distinct cationic antimicrobial peptides.

Cheung AL, Bayer AS, Yeaman MR, Xiong YQ, Waring AJ, Memmi G, Donegan N, Chaili S, Yang SJ.

Infect Immun. 2014 Dec;82(12):5336-45. doi: 10.1128/IAI.02480-14. Epub 2014 Oct 6.

45.

Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons.

Mishra NN, Bayer AS, Weidenmaier C, Grau T, Wanner S, Stefani S, Cafiso V, Bertuccio T, Yeaman MR, Nast CC, Yang SJ.

PLoS One. 2014 Sep 16;9(9):e107426. doi: 10.1371/journal.pone.0107426. eCollection 2014.

46.

Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.

Munita JM, Mishra NN, Alvarez D, Tran TT, Diaz L, Panesso D, Reyes J, Murray BE, Adachi JA, Bayer AS, Arias CA.

Clin Infect Dis. 2014 Nov 1;59(9):1277-80. doi: 10.1093/cid/ciu642. Epub 2014 Aug 8.

47.

Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections.

David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG Jr, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth JJ, Volinski J, Spellberg B.

Clin Infect Dis. 2014 Sep 15;59(6):798-807. doi: 10.1093/cid/ciu410. Epub 2014 May 30.

48.

Genome Sequences of Sequence Type 45 (ST45) Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Strain 300-169 and ST45 Resolving MRSA Bacteremia Strain 301-188.

Hernandez D, Seidl K, Corvaglia AR, Bayer AS, Xiong YQ, François P.

Genome Announc. 2014 Mar 13;2(2). pii: e00174-14. doi: 10.1128/genomeA.00174-14.

49.

Impact of vancomycin on sarA-mediated biofilm formation: role in persistent endovascular infections due to methicillin-resistant Staphylococcus aureus.

Abdelhady W, Bayer AS, Seidl K, Moormeier DE, Bayles KW, Cheung A, Yeaman MR, Xiong YQ.

J Infect Dis. 2014 Apr 15;209(8):1231-40. doi: 10.1093/infdis/jiu007. Epub 2014 Jan 7.

50.

Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.

Sakoulas G, Okumura CY, Thienphrapa W, Olson J, Nonejuie P, Dam Q, Dhand A, Pogliano J, Yeaman MR, Hensler ME, Bayer AS, Nizet V.

J Mol Med (Berl). 2014 Feb;92(2):139-49. doi: 10.1007/s00109-013-1100-7. Epub 2013 Dec 3.

Supplemental Content

Loading ...
Support Center